We recently published a list of 10 Best Mid-Cap Growth Stocks to Buy According to Analysts. In this article, we are going to ...

AbbVie ( ABBV 0.61%) is a leader in biopharmaceuticals with a product portfolio spanning multiple therapeutic areas, ...

To illustrate that point, let's discuss two stocks in the biotech industry that have moved in opposite directions so far this ...

The rankings of the top pharmaceutical companies in the world in 2017 presented a mixed picture, with stability for some of the 25 largest firms as others saw their value fall.

The risk of pharma bribery, the risk of brain drain, and other risks (and rewards) in the biotech landscape this week.

Halozyme Therapeutics, Inc. (NASDAQ:HALO) is a biopharmaceutical company focused on innovative drug delivery technologies, ...

The UK biotech sector raised £3.5 billion in equity financing last year amid challenges, according to a BIA report.

Of course, biotechnology also promises to change the world by transforming ... It will take the best part of 10 years before it’s clear which, if any, of these companies will become major ...

Biotech stocks are in the eye of the storm as the world recovers from the global ... Tilt your stock portfolio toward biotech companies now and you could stand to make substantial profits in ...

Subin Baral, EY global life sciences deals leader, told GEN M&A deals are expected to increase in 2025, driven by biopharmas that are eager to recoup revenues they expect to lose as their aging ...

For context, tech giants still top the global wealth charts. Elon Musk is by far the richest man in the world, with a total ...

BioTech Breakthrough is a leading independent ... industry’s most comprehensive analysis and evaluation of the world’s top companies, solutions, and products in the life sciences and ...